Elevance Health ELV Proceeds from sale of investments
Proceeds from sale of investments at other companies
Other financials
Where this comes from
Reported directly by Elevance Health in its filing.
Tagged under the XBRL concept elv:Proceedsfromsaleofequityandfixedmaturitysecurities.
The official record: Elevance Health’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elevance Health's proceeds from sale of investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Elevance Health's proceeds from sale of investments?
- Elevance Health (ELV) reported proceeds from sale of investments of $3.09B in Q1 2026.
- How has Elevance Health's proceeds from sale of investments changed year-over-year?
- Elevance Health's proceeds from sale of investments decreased by 25.4% year-over-year, from $4.15B to $3.09B.
- What is the long-term trend for Elevance Health's proceeds from sale of investments?
- Over 3 years (2022 to 2025), Elevance Health's proceeds from sale of investments has grown at a 3.6% compound annual growth rate (CAGR), from $11.99B to $13.32B.
- What does proceeds from sale of investments mean?
- Represents the cash inflow received from the sale of investment assets. This is a key source of liquidity for insurers, allowing them to rebalance portfolios or fund operational needs.